DigitCells launches TWO-D at AUA
CHICAGO, April 30,
2024 /PRNewswire-PRWeb/ -- DigitCells, a leading
innovator in complete digital pathology solutions and a subsidiary
company of GoPath Diagnostics, is excited to announce the launch of
its groundbreaking Tissue Workflow Optimization for Digital (TWOD)
system for prostate at the upcoming 2024 American Urological
Association (AUA) Annual Meeting in San
Antonio, Texas.
The TWOD system represents a revolutionary
leap in pathology workflows, delivering unprecedented efficiency
gains and setting a new benchmark in digital pathology." - Dr.
Jim Lu, CEO and Medical Director of
GoPath Diagnostics. Dr. Jim Lu, CEO
and Medical Director of GoPath Diagnostics
The TWOD system ushers in a new era of high-efficiency and
cost-effectiveness in pathology
The TWOD system streamlines biopsy tissue workflows,
significantly enhancing efficiency to meet the demands of today's
pathology environment. It encompasses the entire process, from
initial acquisition in the clinician's office, through
comprehensive tracking within the histology lab, to final digital
sign-out by pathologists. TWOD improves workflow efficiency
providing a greater benefit of digital pathology adoption. This
efficiency gain is achieved through a significant reduction in
traditional consumable usage by up to 33%, leading to a 40%
improvement in overall laboratory productivity. The benefits of
TWOD include- preserved specimen integrity, substantial financial
savings, and heightened diagnostic efficacy. These combined
advantages make digital pathology a more compelling choice for the
modern healthcare system.
Innovation at its Core: Optimizing the Entire Tissue Workflow
for Better Patient Care
The TWOD system's patent-pending cassette design guarantees the
structural integrity of biopsied specimens throughout the
diagnostic process. This innovative design ensures each core is
securely housed within a stable environment from the initial
acquisition. The cassette then facilitates optimal formalin
fixation during transport, minimizing the potential for tissue
fragmentation upon receipt. This preservation approach safeguards
tissue integrity for improved analysis. Our unique barcoding and
color-coded system tracks the specimen during the entire process,
starting from the clinician's site and throughout the histology lab
ensuring complete tissue identity retention. This process is
centrally managed by TWOD's LIS and IMS system which integrates
laboratory information and pathology imaging with embedded
augmented intelligence and pathology sign-out functions.
TWOD is a Leap Towards a Future Where Efficient Digital
Diagnosis is More Accessible
"We are thrilled to unveil the TWOD system at this year's AUA
Annual Meeting," said Dr. Jim Lu,
CEO and Medical Director of GoPath Diagnostics, the parent company
of DigitCells Inc. "The current histology workflow, which has been
used for nearly a century, is not optimized for today's digital
pathology setting. The TWOD system bridges the gap between
histopathology and digital pathology, reducing cost and improving
workflow efficiency. While we are focused on launching TWOD for
prostate, our plans is to expand its capability into GI, breast and
dermatology. We are proud to be setting a new benchmark in the
industry with our TWOD system to help our colleagues embrace
digital pathology in their practice".
Experience TWOD at AUA Booth 823
Visit the TWOD pop-up at AUA at booth 823 to see the system in
action. Live demonstrations will be conducted on Friday, May 3rd, and Saturday, May 4th, from 9
AM to 4 PM. Attendees will have the opportunity to engage
directly with the TWOD system and gain firsthand experience of its
practical benefits and capabilities.
About DigitCells
DigitCells, a leading technology company specializing in
comprehensive digital pathology solutions, empowers pathologists
worldwide to enhance efficiency, accuracy, and collaboration. Our
offerings encompass quality hardware, intuitive software, and
secure cloud-based services designed to support you throughout your
entire digital journey. Partner with DigitCells and experience
high-fidelity image capture, powerful digital capabilities,
streamlined laboratory operation, enhanced collaboration and
knowledge sharing with expert support and guidance every step of
the way. Together, we can unlock the full potential of pathology
and create a more efficient, collaborative, and accurate future for
patients everywhere.
About GoPath
GoPath Diagnostics specializes in molecular, genetics, anatomic
pathology, hematopathology, cytology, and digital pathology
services. With advanced technologies and an experienced team of
laboratory professionals, GoPath Diagnostics provides accurate,
reliable, and timely test results to enable clinical healthcare
providers to make informed treatment decisions and to empower
pathologists by enhancing their molecular and digital
capabilities.
Media Contact
Edgar Castellanos, DigitCells, 1
2245156999, ecastellanos@gopathdx.com, https://digitcells.com/
View original content to download
multimedia:https://www.prweb.com/releases/digitcells-unveils-proprietary-two-d-system-at-aua-2024-revolutionizing-pathology-workflows-302131916.html
SOURCE DigitCells